Discovery of non-glucoside SGLT2 inhibitors

A series of benzothiazinone and benzooxazinone derivatives were discovered as SGLT2 inhibitors. The optimization led to the discovery of compounds 31 and 32, which exhibited similar potency and better SGLT1 selectivity compared to dapagliflozin. These compounds may provide novel promising scaffolds, which are different from phlorizin-based SGLT2 inhibitors.     

Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagonists to the NK3 receptor

A series of 3-aryl-5-acylpiperazinyl-pyrazoles (e.g., 3a-b) initially identified through a high-throughput screening campaign using the aequorin Ca²⁺ bioluminescence assay as novel, potent small molecule antagonists of the G protein-coupled human tachykinin NK₃ receptor (hNK3-R) is described. Preliminary profiling revealed poor plasma and metabolic stability for these structures in rodents. Further optimization efforts resulted in analogs with improved potency, stability, and pharmacokinetic properties as well as good brain permeability, for example, compounds 26 and 42. Unexpected cytotoxicity was observed in such N-Me pyrazole structures as compounds 41-42.     

Synthesis, photophysical and photochemical properties of novel soluble tetra[4-(thiophen-3yl)-phenoxy]phthalocyaninato zinc(II) and Ti(IV)O complexes

The synthesis, photophysical and photochemical properties of zinc and oxo-titanium phthalocyanine derivatives 4-(tetra[4-(thiophen-3yl)-phenoxy]phthalocyaninato)zinc(II), (2); and 4-(tetra[4-(thiophen-3yl)-phenoxy]phthalocyaninato)oxo-titanium(IV), (3), are described for the first time. These peripherally substituted complexes (2 and 3) have been synthesized and characterized by elemental analysis, IR, ¹H NMR and electronic spectroscopy. The compounds (2 and 3) have good solubility in organic solvents such as CHCl₃, DCM, DMSO, DMF, THF and toluene and are not aggregated within a wide concentration range. General trends are described for singlet oxygen, photodegradation, fluorescence quantum yields, triplet quantum yields and triplet life times of these complexes in DMSO, DMF and THF. Compound 2 has higher fluorescence quantum yields, triplet quantum yields and triplet life times than 3, however, the former has lower singlet oxygen quantum yields and photodegradation quantum yields than the latter.     

Zinc(II) and mercury(II) coordination architectures with two pyridyl/benzimidazol-1-yl-based ligands: Crystal structures and photoluminescent properties

In our efforts to investigate the relationships between the structures of ligands and their complexes, two structurally related ligands, 1-(2-pyridylmethyl)-1H-benzimidazole (L¹) and 1-(4-pyridylmethyl)-1H-benzimidazole (L²), and their four complexes, [Zn(L¹)₂Cl₂] (1), [Hg(L¹)Br₂]_∞ (2), {[Zn(L²)Cl₂](CH₃CN)}_∞ (3) and [Hg(L²)Br₂]₂(CH₃CN)₂ (4) were synthesized and structurally characterized by elemental analyses, IR spectra and single-crystal X-ray diffraction analysis. Structural analyses show that 1 has a mononuclear structure, and 2 and 3 both take 1D structure. While 4 takes a dinuclear structure. 1, 2 and 4 were further linked into higher-dimensional supramolecular networks by weak interactions, such as C-H?Cl and C-H?Br H-bonding, C-H?π, and π?π stacking interactions. The structural differences of 1-4 may be attributed to the difference of the spatial positions of the terminal N donor atoms in the pendant pyridyl groups in L¹ and L², in which the pyridine rings may act as the directing group for coordination and the benzimidazole rings act as the directing group for π?π stacking and C-H?π interactions. The luminescent properties of the corresponding complexes and ligands have been further investigated.     

Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is an orphan neurodegenerative disease currently without a cure. Mutations in copper/zinc superoxide dismutase 1 (SOD1) have been implicated in the pathophysiology of this disease. Using a high-throughput screening assay expressing mutant G93A SOD1, two bioactive chemical hit compounds (1 and 2), identified as arylsulfanyl pyrazolones, were identified. The structural optimization of this scaffold led to the generation of a more potent analogue (19) with an EC₅₀ of 170 nM. To determine the suitability of this class of compounds for further optimization, 1 was subjected to a battery of pharmacokinetic assays; most of the properties of 1 were good for a screening hit, except it had a relatively rapid clearance and short microsomal half-life stability. Compound 2 was found to be blood-brain barrier penetrating with a brain/plasma ratio = 0.19. The optimization of this class of compounds could produce novel therapeutic candidates for ALS patients.     

Perfluoroalkylated derivatives of 6-deoxy-6-ethylamino-d-galactose, 1-deoxy-1-methylamino-d-glucitol, and 1-amino-1-deoxy-d-glucitol: syntheses, hemocompatibility, and effect on perfluorocarbon emulsion

N-Polyfluoroalkyl derivatives of 6-deoxy-6-ethylamino-1,2;3,4-di-O-isopropylidene-α-d-galactopyranose (8-10), 1-deoxy-1-methylamino-d-glucitol (13-15), and 1-amino-1-deoxy-d-glucitol (16-18), all possessing perfluoroalkyl segment, were prepared using nucleophilic epoxide ring opening of 2-[(perfluoroalkyl)methyl]oxiranes 1-3. Co-emulsifying properties and hemolytic activity of the new perfluoroalkylated amphiphiles were tested. Both types of the polyol derivatives 8-10 and 13-18 generally displayed good to excellent co-emulsifying properties on testing on perfluorodecalin/Pluronic F-68 microemulsions. Mono-perfluoroalkylated compounds 8-10 and 13-15 displayed high hemolysis, whereas acyclic bis-perfluoroalkylated compounds 16-18 were non-hemolytic even for short perfluorobutyl segment (16). The properties were generally improving with increasing perfluoroalkyl chain length.     

Mn(II) coordination architectures with mixed ligands of 3-(2-pyridyl)pyrazole and carboxylic acids bearing different secondary coordination donors and pendant skeletons

In our efforts to investigate the factors that affect the formation of coordination architectures, such as secondary coordination donors and pendant skeletons of the carboxylic acid ligands, as well as H-bonding and other weak interactions, two kinds of ligands: (a) 3-(2-pyridyl)pyrazole (L¹) with a non-coordinated N atom as a H-bonding donor, a 2,2′-bipyridyl-like chelating ligand, and (b) four carboxylic ligands with different secondary coordination donors and/or pendant skeletons, 1,4-benzenedicarboxylic acid (H₂L²), 4-sulfobenzoic acid (H₂L³), quinoline-4-carboxylic acid (HL⁴) and fumaric acid (H₂L⁵), have been selected to react with Mn(II) salts, and five new complexes, [Mn(L¹)₂(SO₄)]₂ (1), [Mn(L¹)₂(L²)]_∞ (2), [Mn(L¹)(HL³)₂]_∞ (3), Mn(L¹)₂(L⁴)₂ (4), and [Mn(L¹)₂(L⁵)]_∞ (5), have been obtained and structurally characterized. The structural differences of 1-5 can be attributed to the introduction of the different carboxylic acid ligands (H₂L², H₂L³, HL⁴, and H₂L⁵) with different secondary coordination donors and pendant skeletons, respectively. This result also reveals that the typical H-bonding (i.e. N-H?O and O-H?O) and some other intra- or inter-molecular weak interactions, such as C-H?O weak H-bonding and π?π interactions, often play important roles in the formation of supramolecular aggregates, especially in the aspect of linking the multi-nuclear discrete subunits or low-dimensional entities into high-dimensional supramolecular networks.     

Tuning the formation of copper(I) coordination architectures with quinoxaline-based N,S-donor ligands by varying terminal groups of ligands and reaction temperature

Five new complexes [Cu₂(L¹)I₂]_∞ (1), [Cu(L²)I]₂ (2), {[Cu₂(L²)I₂](CH₃CN)₃}_∞ (3), [Cu₂(L³)I₂]_∞ (4) and {[Cu(L³)I](CH₃CN)}₂ (5) have been obtained by reacting three structurally related ligands, 2,3-bis(n-propylthiomethyl)quinoxaline (L¹), 2,3-bis(tert-butylthiomethyl)quinoxaline (L²) and 2,3-bis[(o-aminophenyl)thiomethyl]quinoxaline (L³) with CuI, respectively, at different temperatures. Single crystal X-ray analyses show that 1, 3, 4 possess 1D chain structures, while 2 and 5 are discrete dinuclear molecules. It is interesting that the reactions of CuI with L¹ at room temperature and 0 °C, respectively, only afforded same structure of 1 (1a and 1b), while using L² (or L³) instead, two different frameworks 2 and 3 (or 4 and 5) have been obtained. The structural changes mainly resulted from the different conformations that L² or L³ adopted at different temperatures. Our research indicates that terminal groups of ligands take an essential role in the framework formation, and the reaction temperature also has important effect on the construction of such Cu(I) coordination architectures. Furthermore, the influence of hydrogen bonds on the conformation of ligands and the supramolecular structures of these complexes have also been explored. The luminescence properties of complexes 1, 2, and 4 have been studied in solid state at room temperature.     

New pyridyl modified phosphines: Synthesis and late transition-metal coordination studies

Using a phosphorus based Mannich condensation reaction the new pyridylphosphines {5-Ph₂PCH₂N(H)}C₅H₃(2-Cl)N (1-Cl) and {2-Ph₂PCH₂N(H)}C₅H₃(5-Br)N (1-Br) have been synthesised in good yields (60% and 88%, respectively) from Ph₂PCH₂OH and the appropriate aminopyridine. The ligands 1-Cl and 1-Br display variable coordination modes depending on the choice of late transition-metal complex used. Hence P-monodentate coordination has been observed for the mononuclear complexes AuCl(1-Cl) (2), AuCl(1-Br) (3), RuCl₂(p-cymene)(1-Cl) (4), RuCl₂(p-cymene)(1-Br) (5), RhCl₂(Cp^∗)(1-Cl) (6), RhCl₂(Cp^∗)(1-Br) (7), IrCl₂(Cp^∗)(1-Cl) (8), IrCl₂(Cp^∗)(1′-Cl) (8′), IrCl₂(Cp^∗)(1-Br) (9), cis-/trans-PdCl₂(1-Cl)₂ (10), cis-/trans-PdCl₂(1-Br)₂ (11), cis-PtCl₂(1-Cl)₂ (12) and cis-PtCl₂(1-Br)₂ (13). Reaction of Pd(Me)Cl(cod) (cod = cycloocta-1,5-diene) with either 1 equiv. of 1-Br or the known pyridylphosphines 1′-Cl, 1-OH or 1-H gave the P/N-chelate complexes Pd(Me)Cl(1-Br-1-H) (14)-(17). All new compounds have been fully characterised by spectroscopic and analytical methods. Furthermore the structures of 4, 5, 10 and 16 · (CH₃)₂SO have been elucidated by single crystal X-ray crystallography. A crystal structure of the dinuclear metallocycle trans,trans-[PdCl₂{μ-P/N-{Ph₂PCH₂N(H)}C₅H₄N}]₂ · CHCl₃, 18 · CHCl₃, has also been determined. Here 1-H bridges, using both P and pyridyl N donors, two dichloropalladium centres affording a 12-membered ring with the PdCl₂ units adopting a head-to-tail arrangement.     

Malonato complexes of oxidovanadium(IV): Synthesis, structural characterization and exploration of their insulin mimetic properties

Several bis-malonatooxidovanadium(IV) complexes of the general type [M₂(H₂O)_n][VO(mal)₂(H₂O)] (where M = Li(1), Na(2), K(3), Cs(4) and NH₄(5); n = 3.5, 1, 3, 1 and 1, respectively) were isolated in good yield and high purity. These complexes were fully characterized by various physicochemical techniques (elemental analysis, UV-Vis, IR, EPR, CV, etc.) complexes 1, 2 and 3 were structurally characterized by single crystal X-ray diffraction technique. In vivo antidiabetic properties of bis-malonato complexes 1, 2, 3 and 5 have been studied using Streptozotocin induced diabetic rats. Significant lowering of blood sugar level has been noticed. At the same time these complexes were found to regulate secondary pathophysiological complications like liver damage and lowering of the total antioxidant status (TAS) in diabetic rats. Results of these study are expected to a expand the possibility of designing new oxidovanadium(IV) complexes of O,O chelating ligands with significant antidiabetic properties.     

Synthesis and characterization of cationic rhodium(I) dicarbonyl complexes

Treatment of Rh(acac)(CO)₂ (acac = acetoacetonate) with perchloric acid followed by addition of an α-diimine (α-diimine = 1,4-bis(Ar)-2,3-dimethyl-1,4-diaza-1,3-butadiene, Ar = 3,5-dimethylphenyl, 1; 3,5-di-tert-butylphenyl, 2; and 3,4,5-trimethoxyphenyl, 3; phenyl, 4; and 4-chlorophenyl, 5) generates a series of complexes of the type [Rh(α-diimine)(CO)₂][ClO₄] 6-10 with varying electronic properties of the supporting diimine ligand. X-ray crystal structures have been determined for the α-diimine ligands 1-5, and complexes 6, 8, and 10.     

Synthesis and luminescent properties of the first series of lanthanide complexes based on sebacate and 2,5-pyridinedicarboxylate

By using 2,5-pyridinedicarboxylate and sebacate as rigid and flexible mixed carboxylate linkers, five new 3D lanthanide complexes, [Ln(seb)_0.5(2,5-pydc)(H₂O)] (Ln = Eu (1), Nd (2), Sm (3), Pr (4) and Tb (5), H₂pydc = 2,5-pyridinedicarboxylic acid, H₂seb = sebacate acid) with macroporous structures, have been synthesized. Complexes 1-5 were characterized by elemental analysis, ICP spectrometer and IR spectroscopy. In particular, the structures of 1-3 were further determined by single-crystal X-ray diffraction. Structural analyses reveal that complexes 1-3 have intricate 3D frameworks, which are constructed by 2,5-pyridinedicarboxylate and sebacate ligands. In addition, the thermogravimetric analysis of 1-3 and photoluminescent properties of 1 and 5 are also discussed in detail.     

Synthesis, X-ray structures, electrochemical properties and cytotoxic effects of Co(II) complexes

1-Benzothiazol-2-yl-3,5-dimethyl-1H-pyrazole (1a) and 1-benzothiazol-2-yl-5-(2-hydroxyphenyl)-3-methyl-1H-pyrazole-4-carboxylic acid methyl ester (1b) were reacted with the hexahydrates of cobalt(II) chloride, cobalt(II) nitrate and cobalt(II) perchlorate to give the corresponding complexes 2a-4a and 2b-5b, respectively. Obtained compounds differ in coordination spheres of central atoms. The complex 2a includes a fivefold coordinated cobalt(II) ion, whereas 3a shows a distorted octahedral configuration around the cobalt(II) ion. All complexes were characterised by FTIR spectroscopy, MS and elemental analysis. The X-ray structures of 2a, 3a and 5b complexes were also solved. The cytotoxic properties of the ligand 1a and both series of Co(II) complexes were examined on human leukemia NALM-6 and HL-60 cells and melanoma WM-115 cells. The ligands, were found to have very low cytotoxicity. Complex 3b exhibited the highest cytotoxic activity with IC₅₀ values in the range of 6.9-17.1 μM for three examined cell lines.     

Ruthenium(II) carbonyl chloride complexes containing pyridine-functionalised bidentate N-heterocyclic carbenes: Synthesis, structures, and impact of the carbene ligands on catalytic activities

A series of new ruthenium(II) carbonyl chloride complexes with pyridine-functionalised N-heterocyclic carbenes [Ru(Py-NHC)(CO)₂Cl₂], [Py-NHC = 3-methyl-1-(2-pyridyl)imidazol-2-ylidene, 1 (1a and 1b); 3-methyl-1-(2-picoyl)imidazol-2-ylidene, 2 (2a and 2b); 3-methyl-1-(2-pyridyl)benzimidazolin-2-ylidene, 3 (3b); 3-methyl-1-(2-picoyl)benzimidazolin-2-ylidene, 4 (4a and 4b); 1-methyl-4-(2-pyridyl)-1,2,4-triazoline-5-ylidene, 5 (5a and 5b)] have been prepared by transmetallation from the corresponding silver carbene complexes and characterized by NMR, IR spectroscopy and elemental analysis. In these complexes with bidentate Py-NHC ligands, one CO ligand is trans to the Py ligand. In 1a, 2a, 4a, and 5a, the NHC ligand is trans to the other CO ligand, thus leaving the two Cl⁻ ligands trans to each other. In 1b, 2b, 3b, 4b, and 5b, the NHC ligands are trans to one Cl⁻ ligand, and the two Cl⁻ ligands are cis to each other. The structures for 1b, 2b, 3b and 4b have been determined by single-crystal X-ray diffraction. These complexes are efficient catalysts in the transfer hydrogenation of acetophenone and their catalytic activities are found to be influenced by electronic effect of the N-heterocyclic carbene ligands.     

Synthesis, characterization and luminescence study of dimethyl[2-(arylmethyleneimino)phenolato]gallium complexes. Crystal structure of dimethyl[3,4-dimethoxyphenylmethyleneiminophenolato]gallium

Three dimethylgallium complexes of type Me₂GaL [L = 3,4-dimethoxyphenylmethyleneiminophenolato (1), 4-butoxylphenyl methyleneiminophenolato (2), 2-pyridylphenolato (3)] have been synthesized by the reaction of trimethylgallium with appropriate N-arylmethyleneiminophenol. The complexes obtained have been characterized by elemental analysis, ¹H NMR, FT-IR and mass spectroscopy, respectively. The solid structure of 1 has been determined by X-ray single crystal analysis. The gallium atom was bonded by an oxygen atom and coordinated by an imine nitrogen atom forming one five-membered ring. The stable dimmer was formed by the coordination of bridging oxygen atom of phenolate to another gallium atom. The photoluminescence of complexes 1-3 were studied. The maximum emission wavelengths of 1-3 are between 338 and 362 nm upon radiation by UV light. The Electroluminescent properties of diodes using 1-3 as emitters were measured. The blue/green electroluminescence has been observed.     

Triorganotin(IV) complexes of Schiff base derived from 6-amino-2-mercaptobenzothiazole: Synthesis, characterization and X-ray crystal structures

Nine triorganotin(IV) complexes of the type R₃SnL (L = L1 R = Me 1, Ph 2, PhCH₂3; L = L2 R = Me 4, Ph 5, PhCH₂6; L = L2 R = Me 7, Ph 8, PhCH₂9) have been obtained by reaction of new Schiff base HL1, HL2 or HL3 with triorganotin(IV) chloride in the presence of sodium ethoxide. All the complexes 1-9 were characterized by elemental, IR and NMR spectra analyses. Except for complexes 3, 4, 6, 9, the others were also characterized by X-ray crystallography diffraction analyses, which revealed that complexes 1, 2, 5, 7, 8 were four coordinated and displayed a capped tetrahedron.     

Synthesis of 5-thiodidehydropyranylcytosine derivatives as potential anti-HIV agents

As a part of our ongoing efforts to identify new anti-HIV agents, a 5′-thiopyrano-nucleoside derivative 4, designed based on 4′-thioD4C 1 and cyclohexenylnucleoside 3, was synthesized. The dihydrothiopyran skeleton of 4 was constructed by the ring closing metathesis of 21 which was synthesized from but-2-yne-1,4-diol. After converting the protecting group from MOM to TBS followed by oxidation, a Pummerer-type thioglycosylation reaction of 24 with persilylated uracil gave the desired 5-thiodihydrothiopyranyluracils 25 and 26 as a mixture of anomers. The conversion of 25 to a cytosine derivative and subsequent deprotection gave a 5-thiodidehydropyranosylcytosine derivative 4 in good yield. The anti-HIV activity of 4 was also evaluated.     

Restriction of apical coordination in the square-planar nickel(II) complexes of meso-1,5,8,12-tetramethyl-1,4,8,11-tetraazacyclotetradecane with axially oriented C-methyl groups

Crystal structures of nickel(II) complexes coordinated with cyclam-type macrocyclic tetraamine, meso-1,5,8,12-tetramethyl-1,4,8,11-tetraazacyclotetradecane (L) in two complex salts 1 and 2 have been determined by single-crystal X-ray crystallographic analysis. Complexes in both salts adopted trans-III structure, but the C-methyl groups of L adopted equatorial configuration in 1, while axial in 2. Complex 2 is the first example of complex of cyclam-type tetraamine with only axially oriented C-methyl groups. Complex in 1 adopted six-coordinated octahedral geometry with two water molecules occupying two apical sites, while in 2, apical sites were vacant resulting in four-coordinated square-planar geometry. UV-Vis spectra in various solutions also revealed the formation of octahedral six-coordinated complex for 1 but not for 2. Network of hydrogen bonds involving chloride ion, water, and N-H of L was present in crystals of both 1 and 2. Convenient synthetic paths for 1 and 2 are also presented.     

Gold(I) and silver(I) complexes of 2,3-bis(diphenylphosphino)maleic acid: Structural studies and antitumour activity

The 2:1 and 1:2 adducts of Au(I) and 1:2 adducts of Ag(I) with the diphosphine 2,3-bis(diphenylphosphino)maleic acid (dpmaa) have been prepared in high yields. Crystal structures have been determined for the neutral digold complex (AuCl)₂(dpmaa) · 2thf (1) and the bis-chelated complex [Au(dpmaa)₂]Cl · H₂O · CH₃OH (2). For 1, conformational rigidity imposed by the ethylenic bridge facilitates the formation of short intramolecular Au-Au contacts with no evidence of similar intermolecular contacts. Complex 2 crystallizes with [Au(dpmaa)₂]⁺ cations hydrogen bonded through the carboxyl groups to a water molecule and chloride anion to form a H-bonded chain along the a axis. ³¹P NMR titration of 1 with dpmaa in acetone shows conversion to 2 at Au:P-P ratios less than 1:1 indicating similar high thermodynamic and kinetic stabilities to other bis-chelated [Au(P-P)₂]⁺ complexes containing 5- or 6-membered chelate rings. The ionic Au(I) complex 2 and the analogous Ag(I) complex [Ag(dpmma)₂]NO₃ (3) are highly water soluble. The in vitro cytotoxic activity of 2 was assessed against eight different cell lines and no significant activity was found. The solubility properties and solution behaviour of the complexes are compared to the analogous 1,2-bis(diphenylphosphino)ethane (dppe) complexes and the potential significance of these results to the antitumour properties of chelated 1:2 Au(I)diphosphine complexes are discussed.     

Synthesis, crystal structures and properties of substituted-pyridyl functionalized bis(ethylenedithio)tetrathiafulvalene derivatives and their corresponding Ni(II) and Co(II) complexes

Three substituted-pyridyl functionalized bis(ethylenedithio)tetrathiafulvalene (BEDT-TTF) derivatives 1-3 and their corresponding Ni(II) and Co(II) complexes have been synthesized and characterized. Their electrochemical properties in CH₂Cl₂ solution have been investigated by cyclic voltammetry and two reversible single-electron oxidation waves for the TTF moiety are observed. Crystal structure analyses were carried out for compound 2 as well as for the Co(II) complex of 1 (7).